WILLIAMS SYNDROME

Williams Syndrome — a neurodevelopmental condition with life-threatening cardiovascular complications (supravalvular aortic stenosis) that require lifelong surveillance, where early diagnosis enables the cardiac monitoring that prevents sudden death.

Whole genome sequencing detects the 7q11.23 microdeletion — ranging from typical 1.5Mb to atypical sizes — identifying the ELN haploinsufficiency that causes progressive vascular disease requiring proactive cardiac follow-up.

ELN
GTF2I
GTF2IRD1

About this condition

Williams Syndrome

Williams syndrome (WS) is a contiguous gene deletion disorder caused by a hemizygous microdeletion of approximately 1.5-1.8Mb at chromosome 7q11.23, encompassing 26-28 genes. The elastin gene (ELN) haploinsufficiency is responsible for the cardiovascular features; GTF2I and GTF2IRD1 deletions contribute to the neurocognitive profile. WS affects approximately 1 in 7,500-10,000 births. The deletion is typically de novo (~95%) and mediated by non-allelic homologous recombination between flanking low-copy repeats.

WS produces a distinctive clinical phenotype: cardiovascular disease (supravalvular aortic stenosis — SVAS — in ~75%, peripheral pulmonary stenosis, systemic hypertension), distinctive facial features (periorbital fullness, stellate iris, broad mouth, small jaw), connective tissue abnormalities (joint laxity, soft skin), hypercalcemia (particularly in infancy — ~15-50%), intellectual disability (mild-moderate, mean IQ ~55-60), and a unique cognitive/behavioral profile characterized by hypersociability, excellent verbal abilities relative to visuospatial skills, attention difficulties, and anxiety.

The cardiovascular complications are the primary cause of morbidity and mortality. SVAS is progressive — vascular elastin deficiency causes progressive arterial stenosis not limited to the aorta but potentially affecting any arterial bed. Sudden cardiac death can occur, particularly during sedation and anesthesia, due to coronary artery ostial stenosis and myocardial ischemia. Lifelong cardiology surveillance with echocardiography, blood pressure monitoring, and pre-procedural cardiac risk assessment is mandatory. Anesthesia in WS patients requires specialized protocols due to the risk of cardiovascular collapse.

Anesthesia in Williams syndrome carries elevated mortality risk — coronary artery stenosis can cause fatal ischemia under sedation. Any procedure requiring anesthesia must have pre-operative cardiac assessment by a cardiologist familiar with WS.

Gene locus: 7q11.23 (ELN, GTF2I, GTF2IRD1 — ~1.5-1.8Mb deletion)

Williams syndrome cardiovascular disease is progressive and can be fatal without surveillance. Molecular diagnosis triggers the lifelong cardiac monitoring protocol that prevents sudden death.

Supravalvular aortic stenosis is progressive and potentially fatal — early diagnosis initiates the surveillance that saves lives

SVAS in Williams syndrome is not static — elastin deficiency causes progressive arterial narrowing over years and decades. Regular echocardiographic surveillance identifies progressive stenosis before it becomes hemodynamically critical, enabling timely surgical intervention. Without molecular WS diagnosis, a child with mild developmental delay and subtle facial features may not receive cardiac imaging until symptoms (syncope, exercise intolerance, sudden death) occur. WGS in any child with developmental delay will detect the 7q11.23 deletion, immediately triggering the cardiovascular surveillance protocol.

The unique WS cognitive profile — strong verbal / weak visuospatial — requires specific educational strategies that generic IEPs miss

Williams syndrome produces a distinctive cognitive profile unlike other causes of intellectual disability: relatively preserved verbal abilities and social communication alongside severely impaired visuospatial construction, number processing, and motor planning. Standard educational approaches designed for general intellectual disability do not leverage WS-specific strengths or address WS-specific weaknesses. Molecular diagnosis enables families to access WS-specific educational resources, connect with the Williams Syndrome Association, and implement evidence-based educational strategies designed for this unique cognitive profile.

Williams Syndrome — a neurodevelopmental condition with life-threatening cardiovascular complications (supravalvular aortic stenosis) that require lifelong surveillance, where early diagnosis enables the cardiac monitoring that prevents sudden death.

Williams Syndrome

Williams syndrome cardiovascular disease is progressive and can be fatal without surveillance. Molecular diagnosis triggers the lifelong cardiac monitoring protocol that prevents sudden death.

Supravalvular aortic stenosis is progressive and potentially fatal — early diagnosis initiates the surveillance that saves lives

The unique WS cognitive profile — strong verbal / weak visuospatial — requires specific educational strategies that generic IEPs miss

Others in Rare Diseases

One test. A lifetime of answers.